Osmotica amends IPO

Drug delivery and generics company Osmotica Pharmaceuticals plc (Bridgewater, N.J.) amended on Oct. 1 its proposed IPO on NASDAQ and now plans to sell 8.3 million shares between $14-$16. The company also added Wells Fargo as an underwriter to a slate that included Jefferies, Barclays and RBC Capital Markets.

At the midpoint of its proposed range, the company would raise $124.5 million and be valued at $767 million...